A detailed history of Clarkston Capital Partners, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Clarkston Capital Partners, LLC holds 57,777 shares of PFE stock, worth $1.59 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
57,777
Previous 44,077 31.08%
Holding current value
$1.59 Million
Previous $1.23 Million 35.6%
% of portfolio
0.03%
Previous 0.02%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$27.7 - $31.39 $379,490 - $430,043
13,700 Added 31.08%
57,777 $1.67 Million
Q2 2024

Aug 14, 2024

SELL
$25.26 - $29.6 $146,053 - $171,147
-5,782 Reduced 11.6%
44,077 $1.23 Million
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $681,993 - $885,833
-26,100 Reduced 34.36%
49,859 $1.44 Million
Q3 2023

Nov 02, 2023

SELL
$32.09 - $37.51 $19,254 - $22,506
-600 Reduced 0.78%
75,959 $2.52 Million
Q2 2023

Aug 07, 2023

SELL
$36.12 - $41.79 $33,591 - $38,864
-930 Reduced 1.2%
76,559 $2.81 Million
Q1 2023

May 15, 2023

SELL
$39.39 - $51.28 $86,145 - $112,149
-2,187 Reduced 2.74%
77,489 $3.16 Million
Q4 2022

Feb 13, 2023

BUY
$41.75 - $54.5 $17,869 - $23,326
428 Added 0.54%
79,676 $4.08 Million
Q3 2022

Nov 16, 2022

BUY
$43.76 - $53.42 $48,136 - $58,762
1,100 Added 1.41%
79,248 $3.47 Million
Q2 2022

Aug 10, 2022

SELL
$46.53 - $55.17 $2,373 - $2,813
-51 Reduced 0.07%
78,148 $4.1 Million
Q1 2022

May 09, 2022

SELL
$45.75 - $56.69 $4,026 - $4,988
-88 Reduced 0.11%
78,199 $4.05 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $1.66 Million - $2.46 Million
40,139 Added 105.22%
78,287 $4.62 Million
Q3 2021

Nov 10, 2021

BUY
$39.25 - $50.42 $5,063 - $6,504
129 Added 0.34%
38,148 $1.64 Million
Q2 2021

Aug 16, 2021

SELL
$35.91 - $40.68 $175,061 - $198,315
-4,875 Reduced 11.37%
38,019 $1.49 Million
Q1 2021

May 14, 2021

BUY
$33.49 - $37.77 $1.23 Million - $1.39 Million
36,739 Added 596.9%
42,894 $1.55 Million
Q2 2019

Jul 24, 2019

SELL
$36.98 - $41.52 $49,996 - $56,135
-1,352 Reduced 18.01%
6,155 $0
Q1 2019

Apr 22, 2019

SELL
$37.5 - $41.2 $10.9 Million - $11.9 Million
-289,538 Reduced 97.47%
7,507 $0
Q4 2018

Jan 17, 2019

SELL
$38.47 - $43.86 $129,259 - $147,369
-3,360 Reduced 1.12%
297,045 $12.3 Million
Q3 2018

Oct 18, 2018

BUY
$34.47 - $41.81 $22,922 - $27,803
665 Added 0.22%
300,405 $13.2 Million
Q2 2018

Jul 19, 2018

SELL
$32.98 - $35.16 $74,864 - $79,813
-2,270 Reduced 0.75%
299,740 $10.9 Million
Q1 2018

Apr 25, 2018

BUY
$31.91 - $37.02 $199,437 - $231,375
6,250 Added 2.11%
302,010 $10.7 Million
Q4 2017

Jan 22, 2018

BUY
$33.26 - $35.29 $245,458 - $260,440
7,380 Added 2.56%
295,760 $10.7 Million
Q3 2017

Oct 30, 2017

BUY
$31.0 - $34.15 $8.94 Million - $9.85 Million
288,380
288,380 $10.3 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Clarkston Capital Partners, LLC Portfolio

Follow Clarkston Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarkston Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clarkston Capital Partners, LLC with notifications on news.